Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisei Mushiroda

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Arerugi = [Allergy]|June 16, 2024
[HUMAN LEUKOCYTE ANTIGEN (HLA) GENES ASSOCIATED WITH DRUG ERUPTIONS AND OTHER DRUG ALLERGIC SIDE EFFECTS]Taisei Mushiroda
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 3, 2024
[Pharmacogenetic testing for prevention of severe cutaneous adverse drug reactions]Taisei Mushiroda
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 15, 2014
[Future direction of pharmacogenomics: identification of genes associated with risk of adverse drug reactions using genome-wide association study]Taisei Mushiroda
Allergology International : Official Journal of the Japanese Society of Allergology|April 5, 2025
Pharmacogenetic biomarkers associated with risk of developing severe drug eruptions and clinical implementation of HLA genetic testingTaisei Mushiroda
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 17, 2013
[Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine]Taisei Mushiroda
Journal of Human Genetics|May 9, 2022
Avoidance of cutaneous adverse drug reactions induced by antiepileptic drugs based on pharmacogenomicsTaisei Mushiroda
Genome Medicine|June 4, 2011
Personalizing carbamazepine therapyTaisei Mushiroda, Yusuke Nakamura
The Lancet. Psychiatry|March 6, 2018
The genetics of antipsychotic response in schizophreniaMasashi Ikeda, Taisei Mushiroda
Drug Metabolism and Pharmacokinetics|January 28, 2021
Update on next generation sequencing of pharmacokinetics-related genes: Development of the PKseq panel, a platform for amplicon sequencing of drug-metabolizing enzyme and drug transporter genesKoya Fukunaga, Yukihide Momozawa, Taisei Mushiroda
Drug Metabolism and Pharmacokinetics|October 27, 2018
Gap between the US and Japan in coverage of pharmacogenomic biomarkers by health insurance programs: More coverage is needed in JapanKeiko Hikino, Koya Fukunaga, Taisei Mushiroda
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Arerugi = [Allergy]|June 16, 2024
[HUMAN LEUKOCYTE ANTIGEN (HLA) GENES ASSOCIATED WITH DRUG ERUPTIONS AND OTHER DRUG ALLERGIC SIDE EFFECTS]Taisei Mushiroda
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 3, 2024
[Pharmacogenetic testing for prevention of severe cutaneous adverse drug reactions]Taisei Mushiroda
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 15, 2014
[Future direction of pharmacogenomics: identification of genes associated with risk of adverse drug reactions using genome-wide association study]Taisei Mushiroda
Allergology International : Official Journal of the Japanese Society of Allergology|April 5, 2025
Pharmacogenetic biomarkers associated with risk of developing severe drug eruptions and clinical implementation of HLA genetic testingTaisei Mushiroda
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 17, 2013
[Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine]Taisei Mushiroda
Journal of Human Genetics|May 9, 2022
Avoidance of cutaneous adverse drug reactions induced by antiepileptic drugs based on pharmacogenomicsTaisei Mushiroda
Genome Medicine|June 4, 2011
Personalizing carbamazepine therapyTaisei Mushiroda, Yusuke Nakamura
The Lancet. Psychiatry|March 6, 2018
The genetics of antipsychotic response in schizophreniaMasashi Ikeda, Taisei Mushiroda
Drug Metabolism and Pharmacokinetics|January 28, 2021
Update on next generation sequencing of pharmacokinetics-related genes: Development of the PKseq panel, a platform for amplicon sequencing of drug-metabolizing enzyme and drug transporter genesKoya Fukunaga, Yukihide Momozawa, Taisei Mushiroda
Drug Metabolism and Pharmacokinetics|October 27, 2018
Gap between the US and Japan in coverage of pharmacogenomic biomarkers by health insurance programs: More coverage is needed in JapanKeiko Hikino, Koya Fukunaga, Taisei Mushiroda
Pageof 17